BestPractice Nordic | Independent clinical perspective in a national context
How does pharma ensure knowledge reaches clinical practice when new indications, diagnostic and treatment options are approved? This is the challenge pharma faces but it is also the key to market access success. A process that hasn’t been made any easier during the COVID-19 situation.
